Omixon & PIRCHE® collaborate on Epitope Determination with NGS

17/09/2018

Global molecular diagnostics company Omixon, headquartered in Budapest, and technology company PIRCHE AG, headquartered in Berlin announce a collaboration to deliver the first integrated epitope determination and matching service that leverages whole gene consensus sequences assembled from NGS data of the HLA region. For the first time, fully characterized...

Happy Holidays from Omixon!

22/12/2017

From all of us at Omixon, we wish to all our friends, partners and everyone else we met during the last couple of years a very happy holiday season with our first Omixon Holiday Song – without you, this year would not have been this eventful and exciting. Happy...

Congratulations! Promotions and Other Changes at Omixon

28/07/2017

We are happy to announce some changes in responsibility at Omixon as the following: Marcello Scala, former Director of Sales, EMEA became the Vice President Sales Operations, EMEA & Asia. As VP Sales Operations, Marcello will focus on generating new business directly with customers and through distributors, he...

Omixon Welcomes Afshan Ali as Sales Manager, EMEA

12/04/2017

We are happy to announce that Afshan Ali has joined the team at Omixon’s global headquarters as a Sales Manager for the EMEA (Europe, Middle East and Africa). Afshan is a highly dynamic and successful Business Development Manager with extensive experience in working with Pharma, Diagnostics and Biotechnology companies...

Take a Selfie to be Featured in Our Rock Video!

13/02/2017

Grab your mobile, take a selfie or headshot of your colleagues, send it to us and enjoy the red carpet for a minute! As usual, we are going to cheer-up our audience before our Lunch Symposium at the European Immunogenetics and Histocompatibility Conference (EFI) in May with a short...